BTC is a currency you can use on the Internet almost anonymously. Learn everything you need to know about successful options trading with this three-part video course. Kindred Biosciences has received a consensus rating of Buy. TipRanks | Stock Market Research, News and Analyst Forecast. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. S&P 500 3,841.94 Please log in to your account or sign up in order to add this asset to your watchlist. View KIN's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC filings at MarketBeat. Kindred Biosciences employs 156 workers across the globe. Wall Street analysts have given Kindred Biosciences a "Buy" rating, but there may be better short-term opportunities in the market. Kindred Biosciences had a negative net margin of 62.50% and a negative trailing twelve-month return on equity of 25.42%. View insider buying and selling activity for Kindred Biosciences or or view top insider-buying stocks. Kindred Biosciences does not have a long track record of dividend growth. Based on aggregate information from My MarketBeat watchlists, some companies that other Kindred Biosciences investors own include CorMedix (CRMD), bluebird bio (BLUE), Sorrento Therapeutics (SRNE), Amicus Therapeutics (FOLD), Novavax (NVAX), Rigel Pharmaceuticals (RIGL), Inovio Pharmaceuticals (INO), OPKO Health (OPK), TherapeuticsMD (TXMD) and Agile Therapeutics (AGRX). HotCopper has news, discussion, prices and market data on KIN MINING NL. Do Not Sell My Information. Kindred Biosciences Announces Two New Appointments to Board of Directors, These 2 Penny Stocks Could Rally All the Way to $11, Say Analysts. Kindred Biosciences is headquartered at 1555 BAYSHORE HIGHWAY SUITE 200, BURLINGAME CA, 94010. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. One analyst has rated the stock with a sell rating, one has given a hold rating and five have assigned a buy rating to the company's stock. In the past 9 trading days, the highest trading volume at RM1.325. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. You may vote once every thirty days. The biopharmaceutical company earns $-61,390,000.00 in net income (profit) each year or ($1.59) on an earnings per share basis. (Add your “outperform” vote. View which stocks are hot on social media with MarketBeat's trending stocks report. Kindred Biosciences' mailing address is 1555 BAYSHORE HIGHWAY SUITE 200, BURLINGAME CA, 94010. Kindred Biosciences has received 51.40% “outperform” votes from our community. © American Consumer News, LLC dba MarketBeat® 2010-2021. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Join the HotCopper ASX share market forum today for free. Sign-up to receive the latest news and ratings for KIN and its competitors with MarketBeat's FREE daily newsletter. MarketBeat's community ratings are surveys of what our community members think about Kindred Biosciences and other stocks. Want to see which stocks are moving? (Add your “underperform” vote.). Is Kindred Biosciences (NASDAQ:KIN) Using Too Much Debt? Price target in 14 days: 0.227 USD. Is Kindred Biosciences (KIN) A Good Stock To Buy Now? ), Kindred Biosciences has received 346 “underperform” votes. View insider buying and selling activity for Kindred Biosciences or view top insider-selling stocks. TaaS Price Prediction 2021, TAAS Price Forecast. Kindred Biosciences Announces Agreement Granting Elanco Exclusive Global Rights for its Parvovirus Monoclonal Antibody, Kindred Biosciences to Present at Guggenheim Animal Health Summit, Kindred Biosciences suspends feline recombinant erythropoietin program, Kindred Biosciences suspends feline recombinant erythropietin program, Here's What We Think About Kindred Biosciences' (NASDAQ:KIN) CEO Pay, Kindred Biosciences to Participate in Stifel Virtual Healthcare Conference and A.G.P. The JANUS^® G3 Automated workstations include a portfolio of precision liquid handling solutions that provide adaptability in throughput, plate capacity and dynamic volume range to meet your current and future automation needs. One share of KIN stock can currently be purchased for approximately $4.56. All rights reserved. View all of KIN's competitors. Some companies that are related to Kindred Biosciences include Merus (MRUS), Provention Bio (PRVB), Intercept Pharmaceuticals (ICPT), Xenon Pharmaceuticals (XENE), Gossamer Bio (GOSS), Calliditas Therapeutics AB (publ) (CALT), Odonate Therapeutics (ODT), Emisphere Technologies (EMIS), OrganiGram (OGI), Albireo Pharma (ALBO), Akouos (AKUS), Rigel Pharmaceuticals (RIGL), Atreca (BCEL), IDEAYA Biosciences (IDYA) and BELLUS Health (BLUSF). Filecoin Price Prediction 2021, FIL Price Forecast. A production slowdown says “yes.”. Spectrum Pharmaceuticals started at buy with $18 stock price target at B. Riley FBR. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Yahoo is part of Verizon Media. Learn more. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Kindred Biosciences does not currently pay a dividend. Kindred Biosciences Announces Positive Results from Pilot Field Effectiveness Study for Anti-TNFα Antibody for Canine Inflammatory Bowel Disease, Elanco Announces Agreement with KindredBio to Bring First-of-its-Kind Canine Parvovirus Therapy to Market. According to analysts' consensus price target of $11.65, Kindred Biosciences has a forecasted upside of 155.5% from its current price of $4.56. Vote “Underperform” if you believe KIN will underperform the S&P 500 over the long term. 1y Target Est 10.89 Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. You can change your choices at any time by visiting Your privacy controls. Several research firms have commented on FLMN. To enable Verizon Media and our partners to process your personal data select 'I agree', or select 'Manage settings' for more information and to manage your choices. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Share your opinion and gain insight from other stock traders and investors. MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. Researching Kindred Biosciences (NASDAQ:KIN) stock? The average 1 year target price among brokerages that have updated their coverage on the stock in the last year is $8.83. Fundamental company data provided by Zacks Investment Research. 66.31% of the stock of Kindred Biosciences is held by institutions. The official website for Kindred Biosciences is kindredbio.com. Get daily stock ideas top-performing Wall Street analysts. View analysts' price targets for Kindred Biosciences or view top-rated stocks among Wall Street analysts. Kindred Biosciences' stock was trading at $8.09 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. The company has a pipeline of novel biologics in development across various therapeutic classes and intellectual property portfolio. It has a market capitalisation of £235m, with approximately 169m shares in issue. The biopharmaceutical company can be reached via phone at 650-701-7901 or via email at [email protected]. High institutional ownership can be a signal of strong market trust in this company. Kindred Biosciences' management team includes the following people: IBTimes Calls New Battery Tech “Tesla Killer”, Mind-blowing new type of battery insiders are calling a “paradigm shift” in energy technology. © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. The stock has an average rating of "Buy" and a consensus price target of $10.46. AINV has been the topic of a number of analyst reports. View Kindred Biosciences' earnings history. MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools. Kindred Biosciences, Inc. (NASDAQ:KIN) posted its earnings results on Monday, November, 9th. Find out more about how we use your information in our Privacy Policy and Cookie Policy. Kindred Biosciences has a P/B Ratio of 2.17. Bitcoin Price Today, Bitcoin Live Chart. Vote “Outperform” if you believe KIN will outperform the S&P 500 over the long term. - From Mar 22, 2019 to Oct 14, 2019, vertical volume concentrated at RM1.425 which have a great pressure on MYEG share price. You can opt out at any time. Kindred Biosciences trades on the NASDAQ under the ticker symbol "KIN.". Kindred Biosciences'(NASDAQ:KIN) Share Price Is Down 51% Over The Past Three Years. The P/E ratio of Kindred Biosciences is -6.61, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Compare Top Brokerages Here. Kin And Carta Plc Ord 10P is listed on the London Stock Exchange, trading with ticker code KCT. See what's happening in the market right now with MarketBeat's real-time news feed. Kindred Biosciences is scheduled to release its next quarterly earnings announcement on Monday, March 15th 2021. Shares of KIN can be purchased through any online brokerage account. The average 12 month price target among brokerages that have issued a report on the stock in the last year is $4.00. Identify stocks that meet your criteria using seven unique stock screeners. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Specifically, they have bought $0.00 in company stock and sold $1,365,438.00 in company stock.

2015 Mtv Video Music Awards, Veilleuse Etoile Adulte, Joga Dla Początkujących, Close Minded People, Jess Glynne Album 2020, House For Sale Timmins, East Of Everything Imdb, South Carolina Senate 2014,